Bayer AG shares are facing a make-or-break few weeks, with two upcoming court developments key to stemming a more than $60 billion wipeout in market value since the German company’s ill-fated purchase of Monsanto eight years ago.
Bayer AG shares are facing a make-or-break few weeks, with two upcoming court developments key to stemming a more than $60 billion wipeout in market value since the German company’s ill-fated purchase of Monsanto eight years ago.
<iframe src="https://statesidedaily.com/embed/cluster/2e45b4df6f69119cd7cc3215c8b36ce720381208" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Bayer Shares Hinge On Two Court Decisions After $60 Billion Rout"></iframe>
